NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001808

Registered date:01/07/2009

Fluid attenuated inversion recovery imaging based intravenous recombinant tissue plasminogen activator (rt-PA) therapy

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedIschemic stroke
Date of first enrollment2009/06/01
Target sample size20
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)intravenous recombinant tissue plasminogen activator (rt-PA) therapy

Outcome(s)

Primary Outcome1)Clinical improvement 2)hemorrhagic complication
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) Patients with suspected onset time is over 24 hours 2) Diffusion weighted imaging evidence of significant early ischemic change 3) Other criteria are same as Japan Alteplase Clinical Trial (J-ACT) (stroke 2006;37:1810)

Related Information

Contact

public contact
Name Junya Aoki
Address 577, Matsushima, Kurashiki Japan
Telephone 086-462-1111
E-mail aojyun@med.kawasaki-m.ac.jp
Affiliation Kawasaki Medical School Department of Stroke Medicine
scientific contact
Name Junya Aoki
Address 577, Matsushima, Kurashiki Japan
Telephone 086-462-1111
E-mail aojyun@med.kawasaki-m.ac.jp
Affiliation Kawasaki Medical School Department of Stroke Medicine